INS and early-onset autosomal dominant Alzheimer disease: This result was further confirmed in Alzheimer’s disease model mice, where co-administration of insulin with L-penetratin reported slower memory loss progression in comparison with the co-administration of insulin with D-penetratin or with the single administration of insulin [97].